Views & Analysis Unified systems mean faster clinical trials Inefficient processes, legacy infrastructure and a silo culture are slowing access to critical trial data.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
